Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuroendocrine Tumors × 89Zr-bevacizumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroendocrine Tumors 1 Breast Neoplasms 1

Interventions

lutetium Lu 177 dotatate 5 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Positron-Emission Tomography 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Biopsy 2 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Plastic Surgery Procedures 1 Phlebotomy 1 Octreotide 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Drug Therapy 1 Diet, Mediterranean 1 Cytidine Triphosphate 1 Cholecystectomy 1 Blood Specimen Collection 1 Biopsy, Large-Core Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01338090 2012-04-03

NETPET

University Medical Center Groningen

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡